Metabolomics is the study of small compounds, often known as metabolites, in cells, biofluids, tissues, and organisms on a massive scale. The metabolome refers to the collection of small molecules and their interactions inside a biological system. Metabolomics, or the comprehensive examination of metabolites in a biological system, is a new technology that has the potential to revolutionise precision medicine. Small quantities of metabolites have traditionally been utilised to detect complex metabolic diseases as well as monogenic disorders such inborn metabolic abnormalities. Current metabolomic methods are capable of exact analysis of hundreds to thousands of metabolites, much exceeding the scope of typical clinical chemistry procedures. Metabolomics is a great tool for the pharmaceutical, preventative healthcare, and agricultural industries, among others, because of its non-invasive nature and close link to the phenotypic. We may be able to track the trends of our own metabolome for individualised medications and enhanced treatment techniques in the future, due to the availability of personalised metabolomics
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico